Robotic Gait Rehabilitation in Parkinson's Disease

Trial ID: NCT05218187

Interventional - Phase Unknown - Terminated

The purpose of this study is to investigate the implementation of a novel gait rehabilitation stimulus (G-EO System) that could advance current clinical practices. The goal is to establish the safety and feasibility of gait training using the G-EO System as well as investigating the impact on mobility, function, quality of life, and participatory outcomes. Research Design: We propose a single-blinded, randomized trial of electromechanically-assisted gait training using the G-EO System in patients with Parkinson's disease with gait disability. Specific Aim 1 will establish the safety and feasibility of gait training using the G-EO System. Specific Aim 2 will determine the efficacy of gait training using the G-EO System for improving mobility, function, and quality of life

Conditions

• Parkinson Disease
• Gait Disorder, Sensorimotor

Interventions

• G-EO End-Effector Gait Trainer
• Conventional Physical Therapy Treatment

Eligibility

Inclusion criteria

• Age \> 18years
• Confirmed diagnosis of Parkinson's Disease
• Hoehn and Yahr stage 1 to 3
• Stable course of disease-modifying therapy over the past 3 months
• Mini Mental State Examination \> 24
• Physician approval for exercise
• Stable deep brain stimulation setting for the past year
• Demonstrate a need for functional rehabilitation

Exclusion criteria

• • Severe dyskinesia or severe on-off phenomenon
• Unstable medication regiment
• Any co-morbidity that will interfere with walking
• Conventional physical therapy or G-EO training within the past 6 months
• Height \<1m or \>2m
• Body weight \>150 kg
• Contraindications to G-EO gait training (e.g., bone instability)

Sponsor

Indiana University

Source: ClinicalTrials.gov

Search more clinical trials on myTomorrows